The research focuses on mathematical modeling the combined effects of yttrium-90, a radioisotope used in liver cancer treatment, and immune checkpoint inhibitors, which enhance the immune system response. The aim is to understand the synergistic impact of these treatments on hepatocellular carcinoma, using mathematical models to predict and optimize therapeutic outcomes. This interdisciplinary approach integrates mathematical modeling with oncology and immunology to explore potential strategies for more effective liver cancer treatment.
catholic university
Seoul, Republic of Korea
Department of Biomedicine and Health Sciences